Given the pivotal role of NF-κB-regulated gene products in cartilage degradation, inflammation, and apoptosis [21], inhibition of NF-κB shows promise in treating conditions such as RA or osteoarthritis (OA). This evidence concerns the gene NFKB1 and osteoarthritis.